Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis. - Diel,I.J.; Solomayer,E.F.; Seibel,M.J.; Pfeilschifter,J.; Maisenbacher,H.; Gollan,C.; Pecherstorfer,M.; Conradi,R.; Kehr,G.; Boehm,E.; Armbruster,F.P.; Bastert,G. (Clin Cancer Res, 1999)